Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bogus HIV tests

This article was originally published in The Gray Sheet

Executive Summary

Federal Trade Commission charges David Rothbart, doing business as Medimax, Inc., with falsely representing on the Internet that his tests accurately detect HIV. At the request of the FTC, a federal district court in Orlando, Florida has issued a temporary restraining order against Rothbart. The agency's complaint seeks to permanently enjoin Rothbart and require payment of "consumer redress." Separately, Cyberlinx Marketing settled FTC charges earlier this month that the Internet company falsely represented its HIV home test kits as accurately detecting HIV. Under the stipulated final settlement order, Cyberlinx and its president, Jeffrey Stein, are banned from marketing HIV home test kits and must reimburse the money received from the sale of the kits

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel